Skip to content

AnaptysBio, Inc. ANAB Asset turnover

Asset turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Eli Lilly logo
Eli LillyLLY
0.7×+0.1×
Pfizer logo
PfizerPFE
0.3×0.0×
Amgen logo
AmgenAMGN
0.4×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.4×0.0×
Biogen logo
BiogenBIIB
0.3×0.0×

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Calculated from AnaptysBio, Inc.’s reported figures.

Based on trailing twelve months.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s asset turnover?
AnaptysBio, Inc. (ANAB) reported asset turnover of 0.6× in Q1 2026.
How has AnaptysBio, Inc.'s asset turnover changed year-over-year?
AnaptysBio, Inc.'s asset turnover increased by 128.7% year-over-year, from 0.3× to 0.6×.
What is the long-term trend for AnaptysBio, Inc.'s asset turnover?
Over 5 years (2020 to 2025), AnaptysBio, Inc.'s asset turnover has grown at a 25.7% compound annual growth rate (CAGR), from 0.2× to 0.6×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.